Compare WYETH LTD with AJANTA PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH LTD vs AJANTA PHARMA - Comparison Results

WYETH LTD     Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WYETH LTD AJANTA PHARMA WYETH LTD/
AJANTA PHARMA
 
P/E (TTM) x 27.7 23.5 117.8% View Chart
P/BV x 5.3 4.1 129.0% View Chart
Dividend Yield % 1.3 0.8 149.9%  

Financials

 WYETH LTD   AJANTA PHARMA
EQUITY SHARE DATA
    WYETH LTD
Mar-13
AJANTA PHARMA
Mar-19
WYETH LTD/
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,0441,422 73.5%   
Low Rs818898 91.1%   
Sales per share (Unadj.) Rs298.6233.5 127.9%  
Earnings per share (Unadj.) Rs57.244.0 130.2%  
Cash flow per share (Unadj.) Rs58.452.2 112.0%  
Dividends per share (Unadj.) Rs17.009.00 188.9%  
Dividend yield (eoy) %1.80.8 235.2%  
Book value per share (Unadj.) Rs249.5255.1 97.8%  
Shares outstanding (eoy) m22.7288.02 25.8%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x3.15.0 62.8%   
Avg P/E ratio x16.326.4 61.7%  
P/CF ratio (eoy) x15.922.2 71.7%  
Price / Book Value ratio x3.74.5 82.1%  
Dividend payout %29.720.5 145.1%   
Avg Mkt Cap Rs m21,157102,081 20.7%   
No. of employees `0000.56.8 7.2%   
Total wages/salary Rs m4004,307 9.3%   
Avg. sales/employee Rs Th13,787.43,022.6 456.1%   
Avg. wages/employee Rs Th813.0633.4 128.4%   
Avg. net profit/employee Rs Th2,643.3569.1 464.5%   
INCOME DATA
Net Sales Rs m6,78320,554 33.0%  
Other income Rs m353211 167.3%   
Total revenues Rs m7,13620,765 34.4%   
Gross profit Rs m1,6175,664 28.6%  
Depreciation Rs m27721 3.7%   
Interest Rs m612 47.4%   
Profit before tax Rs m1,9385,143 37.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-50-   
Tax Rs m6321,273 49.7%   
Profit after tax Rs m1,3013,870 33.6%  
Gross profit margin %23.827.6 86.5%  
Effective tax rate %32.624.8 131.8%   
Net profit margin %19.218.8 101.8%  
BALANCE SHEET DATA
Current assets Rs m6,98411,812 59.1%   
Current liabilities Rs m2,0563,776 54.4%   
Net working cap to sales %72.639.1 185.8%  
Current ratio x3.43.1 108.6%  
Inventory Days Days9977 128.3%  
Debtors Days Days2482 29.3%  
Net fixed assets Rs m24414,398 1.7%   
Share capital Rs m227175 129.5%   
"Free" reserves Rs m5,44122,277 24.4%   
Net worth Rs m5,66822,452 25.2%   
Long term debt Rs m257 378.8%   
Total assets Rs m7,90126,962 29.3%  
Interest coverage x353.3444.3 79.5%   
Debt to equity ratio x00 1,500.5%  
Sales to assets ratio x0.90.8 112.6%   
Return on assets %16.514.4 114.8%  
Return on equity %22.917.2 133.1%  
Return on capital %34.023.0 148.3%  
Exports to sales %0.20-   
Imports to sales %36.30-   
Exports (fob) Rs m15NA-   
Imports (cif) Rs m2,465NA-   
Fx inflow Rs m1510,682 0.1%   
Fx outflow Rs m2,6772,102 127.4%   
Net fx Rs m-2,6628,580 -31.0%   
CASH FLOW
From Operations Rs m9233,748 24.6%  
From Investments Rs m317-2,228 -14.2%  
From Financial Activity Rs m-481-1,475 32.6%  
Net Cashflow Rs m75945 1,679.4%  

Share Holding

Indian Promoters % 0.0 73.8 -  
Foreign collaborators % 51.1 0.0 -  
Indian inst/Mut Fund % 11.3 1.6 729.0%  
FIIs % 7.2 7.6 94.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 17.0 178.8%  
Shareholders   21,978 20,968 104.8%  
Pledged promoter(s) holding % 0.0 4.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WYETH LTD With:   ALEMBIC LTD  SUN PHARMA  PFIZER  FDC LTD.  AUROBINDO PHARMA  

Compare WYETH LTD With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 262 Points Lower; Oil & Gas and Banking Stocks Witness Selling(Closing)

Indian share markets witnessed negative trading activity throughout the day and ended lower. At the closing bell, the BSE Sensex stood lower by 262 points (down 0.7%).

Related Views on News

AJANTA PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 8.4% (Quarterly Result Update)

Aug 2, 2019 | Updated on Aug 2, 2019

For the quarter ended June 2019, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 8.4% YoY). Sales on the other hand came in at Rs 6 bn (up 19.8% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 24, 2019 | Updated on Jun 24, 2019

Here's an analysis of the annual report of AJANTA PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of AJANTA PHARMA. Also includes updates on the valuation of AJANTA PHARMA.

AJANTA PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 5.9% (Quarterly Result Update)

May 3, 2019 | Updated on May 3, 2019

For the quarter ended March 2019, AJANTA PHARMA has posted a net profit of Rs 889 m (down 5.9% YoY). Sales on the other hand came in at Rs 5 bn (down 2.9% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (3QFY19); Net Profit Down 54.6% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, AJANTA PHARMA has posted a net profit of Rs 669 m (down 54.6% YoY). Sales on the other hand came in at Rs 5 bn (down 17.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 4.9% (Quarterly Result Update)

Nov 6, 2018 | Updated on Nov 6, 2018

For the quarter ended September 2018, AJANTA PHARMA has posted a net profit of Rs 1 bn (down 4.9% YoY). Sales on the other hand came in at Rs 5 bn (up 0.7% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

More Views on News

Most Popular

Buying these Eight Stocks is Like Owning Your Own Business(Profit Hunter)

Sep 5, 2019

Everyone dreams of owning a business. Here is your chance.

7 Stocks to Buy in the Market Today(The 5 Minute Wrapup)

Sep 5, 2019

The stock market had a four-year bull run starting September 2013. Are we seeing a similar pattern now?

Don't Buy Lakshmi Vilas Bank...Buy this Private Sector Bank with 74% Upside(The 5 Minute Wrapup)

Sep 4, 2019

Lakshmi Vilas Bank is in a vicious cycle. The stock is already down 57% in 2019. Despite this, the retail investors increased their holding.

Insider Buying Alert: Promoters Increase Stake in 8 High-Quality Smallcaps(Profit Hunter)

Sep 3, 2019

Insiders have increased their stakes in eight Hidden Treasure recommendations. Should you follow them?

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

WYETH LTD SHARE PRICE


Dec 9, 2014 (Close)

TRACK WYETH LTD

  • Track your investment in WYETH LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

WYETH LTD - UNICHEM LAB COMPARISON

COMPARE WYETH LTD WITH

MARKET STATS